Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?

Oncogene. 2002 Jan 21;21(4):688-97. doi: 10.1038/sj.onc.1205163.

Abstract

Telomerase activation is observed in almost 90% of human cancers but not in normal tissues of somatic origin and thus is a critical step for multistep carcinogenesis. A more thorough understanding of telomerase regulation may provide not only a molecular basis of cancer progression but also as a way to manipulate telomerase activity as a potential therapeutic modality. Recent progress in studies on telomerase regulation has shown that telomerase activation is achieved at various steps, including transcriptional and post-transcriptional levels of the telomerase reverse transcriptase (hTERT) gene. Although a number of potentially important mechanisms of telomerase activation have been proposed, none of the current models can fully explain tumor-specific activation of telomerase, suggesting a need for further extensive analysis. This review includes a summary of recent works on telomerase regulation and a discussion of how we can overcome this situation.

Publication types

  • Review

MeSH terms

  • Alternative Splicing
  • Antineoplastic Agents / pharmacology
  • Biological Factors / physiology
  • DNA-Binding Proteins
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation, Neoplastic
  • Genetic Therapy
  • Humans
  • Neoplasms / enzymology
  • Neoplasms / genetics
  • Neoplasms / therapy*
  • Phosphorylation
  • Telomerase / antagonists & inhibitors
  • Telomerase / genetics
  • Telomerase / metabolism*
  • Transcriptional Activation

Substances

  • Antineoplastic Agents
  • Biological Factors
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Telomerase